Pharmena S.A.
Develops products based on its patented 1-MNA active ingredient for cellular aging.
PHR | WAR
Overview
Corporate Details
- ISIN(s):
- PLPHRMN00011
- LEI:
- 259400RHT936BBKW0955
- Country:
- Poland
- Address:
- ŁÓDŹ GDAŃSKA 47/49, 90-729 ŁÓDŹ
- Website:
- https://www.pharmena.eu/
- Sector:
- Manufacturing
Description
Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 17:07 |
Pharmena Raport za III kwartał 2025
|
Polish | 643.3 KB | ||
| 2025-09-08 13:56 |
Zawarcie umowy na wykonanie badań biokompatybilności przyszłego wyrobu medyczne…
|
Polish | 1.6 KB | ||
| 2025-07-16 10:53 |
Rozpoczęcie współpracy z Shop Apotheke w zakresie sprzedaży suplementów diety w…
|
Polish | 1.2 KB | ||
| 2025-07-07 10:12 |
Zawarcie umowy na opracowanie dokumentacji oraz wytworzenie serii walidacyjnych…
|
Polish | 2.0 KB | ||
| 2025-06-25 16:52 |
PHR_Wykaz akcjonariuszy posiad. pow. 5% głosów na ZWZ w dniu 25 06 2025
|
Polish | 50.1 KB | ||
| 2025-06-25 16:52 |
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ w dniu 25…
|
Polish | 525 bytes | ||
| 2025-06-25 16:51 |
250625_Informacja dot Jacka Szwajcowskiego
|
Polish | 306.7 KB | ||
| 2025-06-25 16:51 |
250625_Informacja dot Zbigniewa Molenda
|
Polish | 224.2 KB | ||
| 2025-06-25 16:51 |
250625_Informacja dot. Anny Paczkowskiej
|
Polish | 239.0 KB | ||
| 2025-06-25 16:51 |
250625_Informacja dot Tomasz Filipiak
|
Polish | 192.5 KB | ||
| 2025-06-25 16:51 |
250625_Informacja dot Agnieszki Dziki
|
Polish | 146.7 KB | ||
| 2025-06-25 16:51 |
250625_Informacja dot Jacka Dauenhauera
|
Polish | 225.0 KB | ||
| 2025-06-25 16:51 |
Powołanie członków Rady Nadzorczej na nową kadencję - Content (PL)
|
Polish | 1.3 KB | ||
| 2025-06-25 16:50 |
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25 06 2025
|
Polish | 176.8 KB | ||
| 2025-06-25 16:50 |
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25.06.2025 r. - Content (…
|
Polish | 822 bytes |
Automate Your Workflow. Get a real-time feed of all Pharmena S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmena S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmena S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
